Eva L Feldman
Neurology
109 Zina Pitcher Place, 5017 AAT-BSRB
Ann Arbor, MI 48109
[email protected]

Available to mentor

Eva L Feldman
Professor
  • About
  • Links
  • Qualifications
  • Center Memberships
  • Research Overview
  • Recent Publications
  • About

    Dr. Feldman is one of the world’s leading authorities on neurodegenerative disease. Currently, she serves as the University of Michigan James W. Albers Distinguished University Professor and the Russell N. DeJong Professor of Neurology at Michigan Medicine. She is also the Director of the NeuroNetwork for Emerging Therapies and ALS Center of Excellence at Michigan Medicine.

    Feldman has made contributions to biomedical research and clinical care in many critical areas of neurodegenerative disease. Her primary focus has been on amyotrophic lateral sclerosis (ALS), Alzheimer's disease, cognitive decline, and the neurologic complications of diabetes and obesity, as well as how environmental toxins affect the nervous system. She also has conducted pioneering research on developing stem cell therapies to treat these diseases.

    Feldman is annually listed in Best Doctors in America, is a member of the Association of American Physicians and the National Academy of Medicine, and is a Fellow of the American Association for the Advancement of Science. Feldman has authored over 530 articles and 74 book chapters (Google Scholar h-index = 117) with >55,000 citations. She has been continuously NIH-funded since 1989 and has received numerous awards and honors throughout her remarkable career.

    Links
    Qualifications
    • Fellow
      University of Michigan, Neuromuscular Disorders, 1998
    • Residency
      Johns Hopkins Hospital, Neurology, 1987
    • Chief Resident
      Johns Hopkins, Neurology, 1987
    • Internship
      William Beaumont Hospital, Internal Medicine, 1984
    • MD, Medicine
      University of Michigan Medical School, Ann Arbor, 1983
    • PhD, Neuroscience
      University of Michigan Medical School, Ann Arbor, 1979
    • MS, Zoology
      University of Notre Dame, South Bend, 1975
    • BA, Biology and Chemistry
      Earlham College, Richmond, 1973
    Center Memberships
    • Center Member
      Center for Cell Plasticity and Organ Design
    • Center Member
      Biosciences Initiative
    • Center Member
      Caswell Diabetes Institute
    • Center Member
      Center for Computational Medicine and Bioinformatics
    • Center Member
      Taubman Institute
    Research Overview

    Diabetes and obesity complications
    Peripheral neuropathy
    Cognitive decline
    Alzheimer's disease
    Amyotrophic lateral sclerosis (ALS)

    Recent Publications See All Publications
    • Journal Article
      Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis.
      Guo K, Figueroa-Romero C, Noureldein MH, Murdock BJ, Savelieff MG, Hur J, Goutman SA, Feldman EL. Brain, 2024 Feb 1; 147 (2): 665 - 679. DOI:10.1093/brain/awad306
      PMID: 37721161
    • Journal Article
      The amyotrophic lateral sclerosis exposome: recent advances and future directions.
      Goutman SA, Savelieff MG, Jang D-G, Hur J, Feldman EL. Nat Rev Neurol, 2023 Oct; 19 (10): 617 - 634. DOI:10.1038/s41582-023-00867-2
      PMID: 37709948
    • Journal Article
      New perspectives in diabetic neuropathy.
      Eid SA, Rumora AE, Beirowski B, Bennett DL, Hur J, Savelieff MG, Feldman EL. Neuron, 2023 Sep 6; 111 (17): 2623 - 2641. DOI:10.1016/j.neuron.2023.05.003
      PMID: 37263266
    • Journal Article
      Single-cell RNA-seq uncovers novel metabolic functions of Schwann cells beyond myelination.
      Eid SA, Noureldein M, Kim B, Hinder LM, Mendelson FE, Hayes JM, Hur J, Feldman EL. J Neurochem, 2023 Jul; 166 (2): 367 - 388. DOI:10.1111/jnc.15877
      PMID: 37328915
    • Journal Article
      Single-cell RNA sequencing identifies hippocampal microglial dysregulation in diet-induced obesity.
      Henn RE, Guo K, Elzinga SE, Noureldein MH, Mendelson FE, Hayes JM, Rigan DM, Savelieff MG, Hur J, Feldman EL. iScience, 2023 Mar 17; 26 (3): 106164 DOI:10.1016/j.isci.2023.106164
      PMID: 36915697
    • Journal Article
      Amyotrophic lateral sclerosis.
      Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, Sobue G. Lancet, 2022 Oct 15; 400 (10360): 1363 - 1380. DOI:10.1016/S0140-6736(22)01272-7
      PMID: 36116464
    • Journal Article
      Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments.
      Elafros MA, Andersen H, Bennett DL, Savelieff MG, Viswanathan V, Callaghan BC, Feldman EL. Lancet Neurol, 2022 Oct; 21 (10): 922 - 936. DOI:10.1016/S1474-4422(22)00188-0
      PMID: 36115364
    • Journal Article
      Emerging insights into the complex genetics and pathophysiology of amyotrophic lateral sclerosis.
      Goutman SA, Hardiman O, Al-Chalabi A, Chió A, Savelieff MG, Kiernan MC, Feldman EL. Lancet Neurol, 2022 May; 21 (5): 465 - 479. DOI:10.1016/S1474-4422(21)00414-2
      PMID: 35334234
    Featured News & Stories photo of a production worker that is AI generated
    Research News
    First-of-its-Kind ALS Study Funded by CDC
    Funded by the CDC, the Michigan Brain, Health and Environment Study is the first-of-its-kind ALS study led by Drs. Eva Feldman and Stephen Goutman.
    Department News
    A Role for Neurologists in Diabetic Peripheral Neuropathy
    A Role for Neurologists at the University of Michigan in Diabetic Peripheral Neuropathy.
    Department News
    Environmental toxin exposure may predict ALS risk
    Experts say environmental toxin exposure may predict ALS risks.
    Department News
    Drawing a tube of blood could assess ALS risk from environmental toxin exposure
    Drawing a tube of blood could assess ALS risk from environmental toxin exposure, experts say.
    Department News
    Study: Spinal cord stimulation offers unmatched pain relief for diabetic neuropathy
    Study: Spinal Cord Stimulation Offers Unmatched Pain Relief for Diabetic Neuropathy
    Department News
    The mystery of why some people develop ALS
    University of Michigan experts explore the mystery of why some people develop ALS.